These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34146566)

  • 1. Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis.
    Baumgartner M; Lang M; Holley H; Crepaz D; Hausmann B; Pjevac P; Moser D; Haller F; Hof F; Beer A; Orgler E; Frick A; Khare V; Evstatiev R; Strohmaier S; Primas C; Dolak W; Köcher T; Klavins K; Rath T; Neurath MF; Berry D; Makristathis A; Muttenthaler M; Gasche C
    Gastroenterology; 2021 Oct; 161(4):1245-1256.e20. PubMed ID: 34146566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Archaea influence composition of endoscopically visible ileocolonic biofilms.
    Orgler E; Baumgartner M; Duller S; Kumptisch C; Hausmann B; Moser D; Khare V; Lang M; Köcher T; Frick A; Muttenthaler M; Makristathis A; Moissl-Eichinger C; Gasche C
    Gut Microbes; 2024; 16(1):2359500. PubMed ID: 38825783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.
    Zhong W; Lu X; Shi H; Zhao G; Song Y; Wang Y; Zhang J; Jin Y; Wang S
    J Clin Gastroenterol; 2019 Oct; 53(9):660-672. PubMed ID: 29210899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV
    Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
    Bednarska O; Walter SA; Casado-Bedmar M; Ström M; Salvo-Romero E; Vicario M; Mayer EA; Keita ÅV
    Gastroenterology; 2017 Oct; 153(4):948-960.e3. PubMed ID: 28711627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
    BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ileocolonic Histopathological and Microbial Alterations in the Irritable Bowel Syndrome: A Nested Community Case-Control Study.
    Talley NJ; Alexander JL; Walker MM; Jones MP; Hugerth LW; Engstrand L; Agréus L; Powell N; Andreasson A
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00296. PubMed ID: 33464728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms.
    Beatty JK; Akierman SV; Motta JP; Muise S; Workentine ML; Harrison JJ; Bhargava A; Beck PL; Rioux KP; McKnight GW; Wallace JL; Buret AG
    Int J Parasitol; 2017 May; 47(6):311-326. PubMed ID: 28237889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
    Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Experimental Barrier Injury Triggers Ulcerative Colitis-Specific Innate Hyperresponsiveness and Ulcerative Colitis-Type Microbiome Changes in Humans.
    Seidelin JB; Bahl MI; Licht TR; Mead BE; Karp JM; Johansen JV; Riis LB; Galera MR; Woetmann A; Bjerrum JT
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1281-1296. PubMed ID: 34118489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production.
    Wang MX; Lin L; Chen YD; Zhong YP; Lin YX; Li P; Tian X; Han B; Xie ZY; Liao QF
    Pharmacol Res; 2020 Sep; 159():104978. PubMed ID: 32485282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal Microbiome Profiles Polygenic Irritable Bowel Syndrome in Mestizo Individuals.
    Arredondo-Hernández R; Schmulson M; Orduña P; López-Leal G; Zarate AM; Alanis-Funes G; Alcaraz LD; Santiago-Cruz R; Cevallos MA; Villa AR; Ponce-de-León Rosales S; López-Vidal Y;
    Front Cell Infect Microbiol; 2020; 10():72. PubMed ID: 32266159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
    Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
    Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
    World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
    Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
    World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.